Somagenetix

Pharmaceutical Manufacturing • Stadtkreis 1 Altstadt, Zurich, Switzerland • 1-10 Employees

Company overview

Headquarters	Stadtkreis 1 Altstadt, Zurich, Switzerland
Website	somagenetix.com
NAICS	3254
Employees	1-10
Socials

Key Contacts at Somagenetix

Andrin Oswald

Chief Executive Officer

Janine Reichenbach

Co-Founder

Somagenetix Email Formats

Somagenetix uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@somagenetix.com), used 75% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@somagenetix.com	75%
{first initial}.{last name}	j.doe@somagenetix.com	25%

About Somagenetix

Somagenetix is a new company that aims at becoming a leading gene therapy company with first-in-class treatment for phagocyte-related disorders. We are spin-off from the University of Zurich and we are leveraging world-class scientific and clinical expertise to solve unmet medical needs through gene therapy. Carried by a highly experienced scientific team with over 17 years experience in gene therapy research, clinical development and applications, our mission is to cure all patients with Phagocyte Disorders. A cutting-edge technology with a complete & unique platform solving all challenges of ex-vivo gene therapies: specificity, long-term efficacy and safety. Our goal is to cure patients with immunodeficiency, neurodegeneration and cancer with brain metastasis via genetically enhanced phagocytes.

Somagenetix revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,800,000
Total funding	$11,700,000